MGI PHARMA Second Quarter 2007 Financial Results Conference Call to Be Webcast on July 18, 2007

MGI PHARMA, INC. (Nasdaq:MOGN) will webcast its second quarter 2007 financial results conference call with investors live over the Internet on Wednesday, July 18, 2007 at 5:00 p.m. Eastern Time. Lonnie Moulder, President and CEO of MGI PHARMA, and members of the Company’s executive management team, will review financial results, answer questions from analysts and investors, and provide commentary on MGI PHARMA’s business outlook. A press release announcing the Company’s financial results for the second quarter 2007 will be issued on Wednesday, July 18, 2007 after the U.S. financial markets close and prior to the start of the webcast. The live webcast and press release may be accessed by logging on to MGI PHARMA’s corporate website at www.mgipharma.com. Please connect to the Company’s website at least 15 minutes prior to the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archived version of the webcast will be available through July 25, 2007. About MGI PHARMA MGI PHARMA, INC. is a biopharmaceutical company focused in oncology and acute care that acquires, researches, develops and commercializes proprietary products that address the unmet needs of patients. MGI PHARMA has a portfolio of proprietary pharmaceuticals, and intends to become a leading biopharmaceutical company. MGI PHARMA markets Aloxi® (palonosetron hydrochloride) Injection, Dacogen® (decitabine) for Injection and Gliadel® Wafer (polifeprosan 20 with carmustine implant) in the United States. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets.